Abstract
To compare the effect of potentially modifiable lifestyle factors on the incidence of vascular disease in women with and without diabetes. In 1996–2001 over one million middle-aged women in the UK joined a prospective study, providing medical history, lifestyle and socio-demographic information. All participants were followed for hospital admissions and deaths using electronic record-linkage. Adjusted relative risks (RRs) and incidence rates were calculated to compare the incidence of coronary heart disease and stroke in women with and without diabetes and by lifestyle factors. At recruitment 25,915 women (2.1% of 1,242,338) reported current treatment for diabetes. During a mean follow-up of 6.1 years per woman, 21,928 had a first hospital admission or death from coronary heart disease (RR for women with versus without diabetes = 3.30, 95% CI 3.14–3.47) and 7,087 had a first stroke (RR = 2.47, 95% CI 2.24–2.74). Adjusted incidence rates of these conditions in women with diabetes increased with duration of diabetes, obesity, inactivity and smoking. The 5-year adjusted incidence rates for cardiovascular disease were 4.6 (95% CI 4.4–4.9) per 100 women aged 50–69 in non-smokers with diabetes, 5.9 (95% CI 4.6–7.6) in smokers with diabetes not using insulin and 11.0 (95% CI 8.3–14.7) in smokers with diabetes using insulin. Non-smoking women with diabetes who were not overweight or inactive still had threefold increased rate for coronary disease or stroke compared with women without diabetes. Of the modifiable factors examined in middle aged women with diabetes, smoking causes the greatest increase in cardiovascular disease, especially in those with insulin treated diabetes.
Similar content being viewed by others
Abbreviations
- BMI:
-
Body mass index
- CHD:
-
Coronary heart disease
- CI:
-
Confidence interval
- CVD:
-
Cardiovascular disease
- RR:
-
Relative risk
References
Lee WL, Cheung AM, Cape D, Zinman B. Impact of diabetes on coronary artery disease in women and men. Diabetes Care. 2000;23:962–8. doi:10.2337/diacare.23.7.962.
Asia Pacific Cohort Studies Collaboration. The effects of diabetes on the risks of major cardiovascular diseases and death in the Asia-Pacific region. Diabetes Care. 2003;26:360–6. doi:10.2337/diacare.26.2.360.
Adlerberth AM, Rosengren A, Wilhelmsen L. Diabetes and long-term risk of mortality from coronary and other causes in middle-aged Swedish men. Diabetes Care. 1998;21:539–45. doi:10.2337/diacare.21.4.539.
Almdal T, Scharling H, Skov Jensen J, Vestergaard H. The independent effect of Type 2 diabetes mellitus on ischemic heart disease, stroke and death. Arch Intern Med. 2004;164:1422–6. doi:10.1001/archinte.164.13.1422.
Barrett-Connor EL, Cohn BA, Wingard DL, Edelstein SL. Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study. JAMA. 1991;265:627–31. doi:10.1001/jama.265.5.627.
Folsom AR, Rasmussen ML, Chambless LE, Howard G, Cooper LS, Shmidt MI, et al. Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke. Diabetes Care. 1999;22:1077–83. doi:10.2337/diacare.22.7.1077.
Gu K, Cowie CC, Harris MI. Mortality in adults with and without diabetes in a national cohort of the US population 1971–1993. Diabetes Care. 1998;21:1138–45. doi:10.2337/diacare.21.7.1138.
Hu FB, Stampfer MJ, Solomon CG, Liu S, Willett W, Speizer FE, et al. The impact of diabetes mellitus on mortality from all causes and CHD in women. Arch Intern Med. 2001;161:1717–23. doi:10.1001/archinte.161.14.1717.
Janghorbani M, Hu FB, Willett WC, Li TY, Manson JE, Logroscino G, et al. Prospective study of Type 1 and Type 2 diabetes and risk of stroke subtypes. Diabetes Care. 2007;30:1730–5. doi:10.2337/dc06-2363.
Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA. 1979;241:2035–8. doi:10.1001/jama.241.19.2035.
Lotufo PA, Gaziano M, Chae CU, Ajani U, Moreno-John G, Buring JE, et al. Diabetes and all-cause and CHD mortality among US male physicians. Arch Intern Med. 2001;161:242–7. doi:10.1001/archinte.161.2.242.
Stamler J, Vaccaro O, Neaton JD, Wentworth D, Multiple Risk Factor Intervention Trial Research Group. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care. 1993;16:434–43. doi:10.2337/diacare.16.2.434.
Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937–52. doi:10.1016/S0140-6736(04)17018-9.
The Million Women Study Collaborative Group. The Million Women Study: design and characteristics of the study population. Breast Cancer Res. 1999;1:73–80. doi:10.1186/bcr16.
Information and Services Division. Scotland [homepage on the Internet] [cited 14 Jan 2008]. Available from: http://www.isdscotland.org/isd/CCC_FirstPage.jsp.
Hospital Episode Statistics [homepage on the Internet] [cited 14 Jan 2008]. Available from http://www.hesonline.nhs.uk/.
World Health Organization. International Statistical Classification of Diseases and Related Health Problems, vol. 1. Geneva: World Health Organization; 1992.
Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D, et al. Cancer incidence and mortality in relation to BMI in the Million Women Study: cohort study. BMJ. 2007;335:1134–45. doi:10.1136/bmj.39367.495995.AE.
Easton DF, Peto J, Babiker AG. Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group. Stat Med. 1991;10:1025–35. doi:10.1002/sim.4780100703.
McIntosh A, Hutchinson A, Home PD, Brown F, Bruce A, Damerell A, et al. Clinical guidelines and evidence review for Type 2 diabetes: management of blood glucose. Sheffield: ScHARR, University of Sheffield; 2001.
Banks E, Beral V, Cameron R, Hogg A, Langley N, Barnes I, et al. Agreement between general practice prescription data and self-reported use of hormone replacement therapy and treatment for various illnesses. J Epidemiol Biostat. 2001;6:357–63. doi:10.1080/13595220152601837.
Bush TL, Miller SR, Golden AL, Hale WE. Self-report and medical record agreement of selected medical conditions in the elderly. Am J Public Health. 1989;79:1554–6.
UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–53. doi:10.1016/S0140-6736(98)07019-6.
Nathan DM, Cleary PA, Backlund JYC, Genuth SM, Lachin JM, Orchard TJ, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353:2643–53. doi:10.1056/NEJMoa052187.
Banks E, Beral V, Cameron R, Hogg A, Langley N, Barnes I, et al. Comparison of various characteristics of women who do and do not attend for breast cancer screening. Breast Cancer Res. 2002;4(1):R1. doi:10.1186/bcr418.
The West of Scotland Coronary Prevention Study Group. Computerised record linkage: compared with traditional patient follow-up methods in clinical trials and illustrated in a prospective epidemiological study. J Clin Epidemiol. 1995;48:1441–52. doi:10.1016/0895-4356(95)00530-7.
Kendrick S, Clarke J. The Scottish Record Linkage System. Health Bull (Edinb). 1993;51:72–9.
Information and Statistics Division NHS Scotland. NHS Scotland Quality Assurance Report on Acute Inpatient/Day case Data 2001–2002, Vol. 2005. Scotland: ISD; 2004.
Liu B, Sweetland S, Beral V, Green J, Balkwill A, Casabonne D. Self-reported information on joint replacement and cholecystectomy agrees well with that in medical records. J Clin Epidemiol. 2007;60:1190–4. doi:10.1016/j.jclinepi.2007.02.007.
Acknowledgments
We thank the many women who completed questionnaires for this study, staff at the collaborating breast screening units and the Million Women Study coordinating centre and the Information and Statistics Division in Scotland and the Information Centre for Health and Social Care for access to hospital admissions data. The Million Women Study is supported by Cancer Research UK, the Medical Research Council, and the NHS Breast Screening Programme. The researchers act independently of the funders.
Author information
Authors and Affiliations
Consortia
Corresponding author
Rights and permissions
About this article
Cite this article
Spencer, E.A., Pirie, K.L., Stevens, R.J. et al. Diabetes and modifiable risk factors for cardiovascular disease: the prospective Million Women Study. Eur J Epidemiol 23, 793–799 (2008). https://doi.org/10.1007/s10654-008-9298-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10654-008-9298-3